AKBIYIK, I. And ÜRÜN, Y. 2023. Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer. FUTURE ONCOLOGY , no.39 , 2585-2591.

AKBIYIK, I., & ÜRÜN, Y., (2023). Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer. FUTURE ONCOLOGY , no.39, 2585-2591.

AKBIYIK, ILGIN, And YÜKSEL ÜRÜN. "Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer," FUTURE ONCOLOGY , no.39, 2585-2591, 2023

AKBIYIK, ILGIN And ÜRÜN, YÜKSEL. "Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer." FUTURE ONCOLOGY , no.39, pp.2585-2591, 2023

AKBIYIK, I. And ÜRÜN, Y. (2023) . "Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer." FUTURE ONCOLOGY , no.39, pp.2585-2591.

@article{article, author={ILGIN AKBIYIK And author={YÜKSEL ÜRÜN}, title={Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer}, journal={FUTURE ONCOLOGY}, year=2023, pages={2585-2591} }